Sandoz plans to build a Biosimilar Technical Development Center in Slovenia
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026
Planned investment of approximately USD 90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
Piramal Pharma plans to offer fully paid-up equity shares through a rights issue to its existing eligible shareholders
Long COVID is a debilitating chronic condition that has affected over 100 million people globally
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
This product will be launched through Granules Consumer Health (GCH) division
Subscribe To Our Newsletter & Stay Updated